United Therapeutics Expands Organ Manufacturing Capabilities with Opening of Third Designated Pathogen-Free Xenograft Production Facility

This company pioneered transplants with genetically modified pig organs. Now they’ve opened a Houston office

The company’s third such facility will focus on commercial production for genetically modified organs, if and when United Therapeutics receives federal approval for its xeno-organs.

United Therapeutics Expands Organ Manufacturing Capabilities with Opening of Third Designated Pathogen-Free Xenograft Production Facility

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Oct 20, 2026-

Generation Park lands new facility to scale xeno-organ production

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park. The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs …

United Therapeutics Opens Xeno-Organ Plant in Houston

United Therapeutics has opened a new facility in Houston's Generation Park built to manufacture pig organs engineered for human transplant, a milestone the company says pushes it closer to supplying kidneys and hearts to patients who might otherwise die waiting for one. The facility, which opened Tuesday, is the company's third Designated Pathogen-Free production site, joining locations in Virginia and Minnesota. A Third Facility Built for Scale…